Author:
Zargar Homayoun,Aning Jonathan,Ischia Joseph,So Alan,Black Peter
Publisher
Springer Science and Business Media LLC
Reference89 articles.
1. Tolley, D. A. et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J. Urol. 155, 1233–1238 (1996).
2. Sylvester, R. J., Oosterlinck, W. & van der Meijden, A. P. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta–T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J. Urol. 171, 2186–2190, quiz 2435 (2004).
3. Dalton, J. T., Wientjes, M. G., Badalament, R. A., Drago, J. R. & Au, J. L. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients. Cancer Res. 51, 5144–5152 (1991).
4. Maeda, T., Kikuchi, E., Matsumoto, K., Miyajima, A. & Oya, M. Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumor. J. Urol. 185, 802–806 (2011).
5. Ersoy, H. et al. Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study. Drug Des. Devel. Ther. 7, 1–6 (2013).
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献